The U.S. Food and Drug Administration on Friday approved three new natural food color additives, part of Department of Health ...

Lars Fruergaard Jørgensen, the boss of Danish pharmaceutical giant Novo Nordisk, explained what impact the drugs can have on users weight in the long run ...

Weight loss drugs like Ozempic and Wegovy, originally for diabetes, are now in high demand as they enable significant fat ...

Implantica AG (FRA:8IM1) reports a 25% sales increase and a robust patent portfolio, while navigating operational losses and regulatory hurdles.

Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment ...

Wegovy and Ozempic remain on the FDA's shortages list, despite strenuous efforts by Novo Nordisk to ramp up its production capacity for semaglutide. The Danish drugmaker has asked the FDA to move ...

On the other hand, Q1 sales of diabetes drug Ozempic hit DKK 32.72 billion, easily surpassing analysts’ consensus of DKK 31.5 billion. The U.S. Food and Drug Administration (FDA) had earlier given ...

Health and wellness companies are embracing weight-loss drugs and building offerings around them in an effort to avoid the ...

Health retailer The Vitamin Shoppe has seen a spike in demand for supplements that could help with loss of appetite, ...